TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry | #o | #f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/2/26 16:27 | 9/30/26 | CRL | Charles River Laboratories International, Inc. | Health | Biolab | Commercial Physical & Biologi | 2 | 2 | P | 7 | 209.66 | 0 | 0 | 0 | 55 | D | |||||||||||||||
9/14/26 20:47 | 9/10/26 | ONMD | Onemednet Corp | DE | Health | Biolab | Commercial Physical & Biologi | 5 | 16 | P.dm | 5,267 | 0.6449 | 0 | 8,166 | 35 | 31,328 | D | ||||||||||||||
7/6/26 16:06 | 6/30/26 | ABSI | Absci Corp | Health | Biolab | Commercial Physical & Biologi | 5 | 8 | P | 1,367 | 3.25 | 0 | 421 | 85 | 919 | D | |||||||||||||||
2/19/26 17:02 | 2/17/26 | NRC | National Research Corp | DE | Health | Biolab | Commercial Physical & Biologi | 2 | 2 | P | 108 | 12.33 | 0 | 9 | 6 | 160 | I | ||||||||||||||
11/10/25 08:30 | 11/6/25 | OABI | Omniab, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 1 | 1 | P.m | 108 | 1.39 | 0 | 77 | 3 | 2,929 | D | ||||||||||||||
8/13/25 19:48 | 8/13/25 | MXCT | Maxcyte, Inc. | DE | Health | Biolab | Commercial Physical & Biologi | 4 | 4 | P | 369 | 1.34 | 0 | 275 | 45 | 886 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |